Comments
Loading...
CARISMA Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:CARM | Benzinga
CARISMA Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Apr 8
EPS Estimate
$-0.220
Quarterly Revenue Estimate
$5.42M
Annual Revenue
(as of Sep 30)
(as of Sep 30)
$20.27M
Analyze the earnings history of CARISMA Therapeutics using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CARM | CARISMA Therapeutics | -$0.46 | -$0.28 | — | — | $3.40M | $4.69M | — | — | 05/08/2025 | Get Alert |
| CARM | CARISMA Therapeutics | -$0.52 | -$0.22 | — | — | $4.29M | $5.42M | — | — | 04/08/2025 | Get Alert |
| CARM | CARISMA Therapeutics | -$0.53 | -$0.28 | -$0.31 | -10.71% | $3.83M | $4.97M | $3.38M | -31.89% | 11/07/2024 | Get Alert |
| CARM | CARISMA Therapeutics | -$0.49 | -$0.30 | -$0.27 | 10.00% | $3.56M | $3.92M | $9.20M | 134.62% | 08/08/2024 | Get Alert |
| CARM | CARISMA Therapeutics | -$1.93 | -$0.43 | -$0.46 | -6.98% | $3.24M | $4.40M | $3.40M | -22.80% | 05/09/2024 | Get Alert |
| CARM | CARISMA Therapeutics | — | -$0.55 | -$0.52 | 5.45% | — | $2.90M | $4.29M | 47.90% | 04/01/2024 | Get Alert |
| CARM | CARISMA Therapeutics | -$8.37 | -$0.57 | -$0.53 | 7.02% | $2.58M | $1.20M | $3.83M | 218.92% | 11/09/2023 | Get Alert |
| CARM | CARISMA Therapeutics | -$7.20 | -$0.60 | -$0.49 | 18.33% | $2.70M | $1.07M | $3.56M | 232.71% | 08/10/2023 | Get Alert |
| CARM | CARISMA Therapeutics | -$5.49 | -$0.89 | -$1.93 | -116.85% | $822.00K | $3.73M | $3.24M | -13.06% | 05/11/2023 | Get Alert |
CARISMA Therapeutics (CARM) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-11-07 | $-0.31 | $-0.28 | -10.7 % |
| Q2 | 2024-08-08 | $-0.27 | $-0.30 | 10.0 % |
| Q1 | 2024-05-09 | $-0.46 | $-0.43 | -6.98 % |
| Q4 | 2024-04-01 | $-0.52 | $-0.55 | 5.45 % |
CARISMA Therapeutics (CARM) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-11-07 | $3.39M | $4.97M | -31.9 % |
| Q2 | 2024-08-08 | $9.20M | $3.92M | 134.6 % |
| Q1 | 2024-05-09 | $3.40M | $4.40M | -22.8 % |
| Q4 | 2024-04-01 | $4.29M | $2.90M | 47.9 % |
FAQ
When is CARISMA Therapeutics (NASDAQ:CARM) reporting earnings?
CARISMA Therapeutics (CARM) is scheduled to report earnings on May 8, 2025. The last reported earnings were for reported on November 7, 2024 for Q3.
What were the latest earnings per share (EPS) for CARISMA Therapeutics (NASDAQ:CARM)?
The Actual EPS was $-0.31, which missed the estimate of $-0.28.
What were CARISMA Therapeutics’s (NASDAQ:CARM) revenues?
The Actual Revenue was $3.4M, which missed the estimate of $5M.
Browse earnings estimates, EPS, and revenue on all stocks.